Journal
MINI-REVIEWS IN MEDICINAL CHEMISTRY
Volume 17, Issue 18, Pages 1746-1757Publisher
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1389557516666160219122524
Keywords
Bioactive(s) delivery; cancer; chemotherapeutics; nanomedicine; theranostics; WHO
Categories
Funding
- Indian Council of Medical Research (ICMR) India
- Council of Scientific & Industrial Research (CSIR), New Delhi
- Department of Science and Technology (DST), India
- ICMR
- CSIR
- DST-INSPIRE
Ask authors/readers for more resources
In the recent years, theranostic nanomedicine based strategies have gained much attention in the field of oncology particularly, in the development of new generation cancer diagnostic and therapeutic tools. Today, various approaches have been developed for bioactive(s) targeting to predefined pathological sites, as well as for quantification of physiological processes and visualization. Significant attempts have been made to combine therapeutic and diagnostic properties in to a single effective nanomedicine formulation. This concept, coined as theranostics is smart nanosystem(s), able to diagnose, bioactive(s) delivery and monitoring of therapeutic response. By combining therapeutic functionalities with molecular imaging, theranostic based strategies may be beneficial in the selection of therapy, planning of treatment, monitoring of objective response and planning of follow-up therapy based on the specific molecular characteristics of a disease. In this manuscript, we reviewed the recent development of theranostic approaches, various nanosystems as theranostic agents and applications of theranostic in cancer therapeutics and diagnostics.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available